Antipsychotics in Youth: Balancing Metabolic Risk
Psychopharmacology and Psychiatry Updates · Psychopharmacology Institute
December 7, 20248m 27s
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In this episode, we explore the cardiac and metabolic safety profile of antipsychotics in youth, based on a World Health Organization Safety Database analysis. We discuss age-dependent risks, specific medication concerns, and the importance of monitoring. How can clinicians balance the benefits of antipsychotics with potential cardiometabolic risks in young patients?
Faculty: David Rosenberg, M.D. Host: Richard Seeber, M.D.